Navigation Links
QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Fourth Quarter and Year End 2007 Earnings and 2008 Guidance Conference Call on the Web
Date:1/30/2008

VENLO, The Netherlands, Jan. 30 /PRNewswire-FirstCall/ -- In conjunction with QIAGEN's Fourth Quarter and Year End 2007 Earnings release, you are invited to listen to its conference call which will be broadcast live over the Internet on Tuesday, February 12, 2008 at 9:30 a.m. ET, with Peer M. Schatz, President and Chief Executive Officer and Roland Sackers, Chief Financial Officer.

What: QIAGEN N.V. -- Fourth Quarter and Year End 2007 Earnings and

2008 Guidance Announcement

When: Tuesday, February 12, 2008 at 9:30 a.m. ET

Where: http://www.QIAGEN.com/goto/120208

How: Live over the Internet -- Simply log on to the Web at the

address above.

The corresponding presentation slides are available to download in the investor relations section of QIAGEN's website at: http://www.QIAGEN.com/goto/120208

Contact: Steve Suriano, Russo Partners, 212-845-4235

QIAGEN N.V., a Netherlands holding company, is a leading provider of innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. QIAGEN has developed a comprehensive portfolio of more than 500 proprietary, consumable products and automated solutions for sample collection, and nucleic acid and protein handling, separation, and purification. QIAGEN also supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics. The company's products are sold to academic research markets, and to leading pharmaceutical and biotechnology companies; as well as to diagnostics laboratories. QIAGEN also provides purification and testing solutions to applied testing markets: such as forensics, animal or food testing, and pharmaceutical process control.

QIAGEN employs more than 2,600 people worldwide. QIAGEN products are sold through
'/>"/>

SOURCE QIAGEN N.V.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Healthcare Technologies Ltd. (NASDAQ: HCTL) Announces Extension of Letters of Intent to Acquire Majority Interest in Two Ethanol Plants
2. HealthCare Technologies Ltd. (NASDAQ: HCTL) Announces Receipt of NASDAQ Delisting Notice
3. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q1/08 Review Issued By Scimitar Equity Research, Inc.
4. Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
5. Neurobiological Technologies, Inc. (Nasdaq: NTIID)
6. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
7. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
8. Alexion Pharmaceuticals Invites You to Participate in its Fourth Quarter and Full Year 2007 Results Conference Call and Web Cast
9. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Piper Jaffray Conference
11. Lev Pharmaceuticals Invites You to Participate in its Q307 Earnings Results Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013  Continuing its long history of proven ... Beckman Coulter , Inc. announces the U.S. Food and ... AccuTnI+3 troponin I assay for use on its Access ... on Beckman Coulter,s troponin I test for ... the proven performance to continue providing dependability to laboratories ...
(Date:6/19/2013)... 19, 2013 Bayer CropScience will honor ... Bee Care Community Leadership Award. The award will be ... Reception in Washington, D.C., an event where supporters of ... world’s food supply. , The Bayer Bee Care ... power of the honey bee colony to benefit their ...
(Date:6/19/2013)... ANGELES , June 19, 2013 Biotechnology industry ... teaming up with financial software provider BlackLine Systems ... SAP ) for a webinar next week entitled ... Uses Solutions from BlackLine and SAP to Help Keep Its ... (Logo: http://photos.prnewswire.com/prnh/20061117/LAF027LOGO ) The webinar, geared ...
(Date:6/19/2013)... 19, 2013 BioConvergence team members ... faculty at 2013’s BioLogistics Summit in San Francisco ... by Cold Chain IQ and IQPC, addressed the ... is, in part, attributed to current trends of ... within these trends is an increase in movement, ...
Breaking Biology Technology:Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 4Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 2Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 4BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2
... GPRO ) announced today that the Company will present ... Tuesday, November 18,2008 at approximately 3:10 p.m. Eastern Time. ... be accessed through a link on the investors,section of ... available for 30 days following the event., About ...
... November 14, 2008 at 9:00 a.m. Eastern ... ... Inc. (Nasdaq: ALSE ) today reports operational and,financial results for the ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080813/NEW056LOGO ), "We are encouraged by the ...
... PharmAthene, Inc.,(NYSE Alternext US: PIP), a biodefense company ... reported,financial and operational results for the third quarter ... the third quarter of 2008, PharmAthene recognized revenues ... same period of 2007. For the nine,months ended ...
Cached Biology Technology:Gen-Probe to Webcast Presentation at the Lazard Capital Markets 5th Annual Healthcare Conference 2Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 2Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 3Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 4Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 5Pharmathene Reports Third Quarter 2008 Financial and Operational Results 2Pharmathene Reports Third Quarter 2008 Financial and Operational Results 3Pharmathene Reports Third Quarter 2008 Financial and Operational Results 4Pharmathene Reports Third Quarter 2008 Financial and Operational Results 5Pharmathene Reports Third Quarter 2008 Financial and Operational Results 6Pharmathene Reports Third Quarter 2008 Financial and Operational Results 7
(Date:6/18/2013)... Laboratory of Molecular Biology, has been honored as ... Award. Torrent is being recognized for his outstanding ... predict antimicrobial regions in proteins. Luis Rivas, Centro ... this algorithm to interrogate full genomes in order ... appealing results." , Torrent obtained his Ph.D. ...
(Date:6/18/2013)... estimated that between 5% and 10% of breast and ... say that these tumours are attributable to inherited mutations ... BRCA2. In patients with these mutations, PARP inhibitors, which ... that make them a new option for personalised cancer ... studies indicate that a fraction of these patients generate ...
(Date:6/17/2013)... nervous system infections may well be suffering from the ... study to be published in mBio , the ... Researchers have detected the virus in spinal fluid from ... infections of unknown cause, and in an average of ... suggesting animals may serve as reservoirs for transmission to ...
Breaking Biology News(10 mins):The American Society for Microbiology honors Marc Torrent 2An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2New virus discovered in patients with central nervous system infections 2New virus discovered in patients with central nervous system infections 3
... global study has found all forms of tobacco exposure, whether ... the risk of heart attack. , The study by professors ... School of Medicine at McMaster University and Hamilton Health Sciences ... Lancet. , In collaboration with colleagues from 52 countries, they ...
... have found that years after experiencing childhood polio, ... expected in their elderly counterparts, but rather experience ... with normal aging. , "Other researchers have suggested ... in life, but we've actually found it to ...
... South African scientists working at the epicenter of the ... human immunodeficiency virus (HIV) "exhausts" killer T cells that ... HIV can simply "turn off" fully functional T cells ... test tube studies, however, the scientists showed that they ...
Cached Biology News:Global study shows all tobacco bad for the heart 2Global study shows all tobacco bad for the heart 3Survivors of childhood polio do well decades later as they age 2How HIV 'exhausts' killer T cells 2How HIV 'exhausts' killer T cells 3How HIV 'exhausts' killer T cells 4
... is a fully automated microplate luminescence ... widest possible range of applications based ... assays luciferase, -galactosidase, gene activities with ... Luminescent Immunoassays Cell-based assays ...
... These handy dispensers save space and ... and other garb. They are the ... parts used in labs, processing and ... charges and the particles they attract. ...
... Double staining is a technique used to ... tissue.(1-6) PicTure™-Double Staining Kit is a Zymed ... two antigens simultaneously in the same human ... The antigens can be identified using two ...
... exciting product for cell-based kinetic assays and ... use of expensive HTS equipment, which lead ... assay development stage. The NOVOstar offers the ... well as any other assay suitable for ...
Biology Products: